Cancer immunotherapy: targeting the difference

J Hepatol. 2014 Nov;61(5):1175-7. doi: 10.1016/j.jhep.2014.06.023. Epub 2014 Jun 30.

Authors

Sarene Koh¹, Antonio Bertoletti²

Affiliations

¹ Viral Hepatitis Laboratory, Singapore Institute for Clinical Sciences, A(∗)STAR, Singapore.
² Viral Hepatitis Laboratory, Singapore Institute for Clinical Sciences, A(∗)STAR, Singapore; Program Emerging Infectious Diseases, Duke-NUS Graduate Medical School, Singapore; School of Immunity and Infection, College of Medical and Dental Science, University of Birmingham, Edgbaston, Birmingham, UK. Electronic address: antonio@duke-nus.edu.sg.

PMID: 24993529
DOI: 10.1016/j.jhep.2014.06.023

No abstract available

Keywords: Cancer; Immunotherapy; Tumour infiltrating lymphocytes.

Publication types

Comment

MeSH terms

Adaptor Proteins, Signal Transducing / genetics*
Adoptive Transfer / methods*
Bile Duct Neoplasms / therapy*
Bile Ducts, Intrahepatic*
CD4-Positive T-Lymphocytes / immunology*
Cholangiocarcinoma / therapy*
Female
Humans
Lymphocytes, Tumor-Infiltrating / transplantation*
Th1 Cells / transplantation*

Substances

Adaptor Proteins, Signal Transducing